Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13638861 | 0.87 | EPHX2 (0.35) | CYP19A1ALDH1A1 | |
| SCHEMBL13162616 | 0.87 | EPHX2 (0.35) | CYP19A1ALDH1A1 | |
| SCHEMBL12094247 | 0.87 | EPHX2 (0.35) | CYP19A1ALDH1A1 | |
| SCHEMBL10077154 | 0.87 | NPC1 (0.31) | — | |
| SCHEMBL18033933 | 0.87 | NPC1 (0.31) | — | |
| SCHEMBL12296 | 0.87 | NPC1 (0.31) | — | |
| SCHEMBL2668613 | 0.86 | NPC1 (0.31) | — | |
| SCHEMBL12787632 | 0.86 | NPC1 (0.31) | — | |
| SCHEMBL24954418 | 0.83 | — | — | |
| SCHEMBL12187755 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8178531-B2 | Antiviral agents | ENANTA PHARMACEUTICALS, INC. (US) | 2012-05-15 | — | — | US | disclosed |
| US-20110218175-A1 | ANTIVIRAL AGENTS | ENANTA PHARMACEUTICALS, INC. | 2011-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110218175-A1 | ANTIVIRAL AGENTS | EIF2AK2, HAVCR2, MAVS | CYP19A1 3113/4885ALDH1A1 1201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.